DA-JC4 is a dual GLP-1/GIP receptor agonist and can be used for the research of neurological disease and insulin signaling pathways.
IC50&Target
GLP-1/GIP
体外研究
DA-JC4 (1~100 nM; hippocampal cells) inhibits rotenone-induced hippocampal neuron death and significantly suppresses Cyt C, Bax and Caspase activation.
体内研究
DA-JC4 (10 nmol/kg; i.p.; once-daily for 14 days) significantly prevents spatial learning deficits in a Y- maze test and Morris water maze tests, and decreases phosphorylated tau levels in the rat cerebral cortex and hippocampus.
DA-JC4 (25 nmol/kg; i.p.; 6 days) shows high levels expression of tyrosine Hydroxylase in the s. nigra and increases expression of neuroprotective growth factor Glial-Derived Neurotrophic Factor (GDNF).
DA-JC4 (50 nmol/kg; i.p.; once-daily for 7 days) improves Parkinson's disease symptom potentially and enhances neurotransmission.
Animal Model:
Male Sprague-Dawley rats (210–230 g)
Dosage:
10 nmol/kg
Administration:
I.p.
Result:
Significantly prevented spatial learning deficits in a Y- maze test and Morris water maze tests, and decreased phosphorylated tau levels in the rat cerebral cortex and hippocampus.
Animal Model:
Adult male C57BL/6 mice (8 week-old)
Dosage:
25 nmol/kg/day
Administration:
I.p.
Result:
Showed high levels expression of tyrosine Hydroxylase in the s. nigra and increased expression of neuroprotective growth factor Glial-Derived Neurotrophic Factor (GDNF).
Animal Model:
Adult male Sprague-Dawley (SD) rats (230-280 g)
Dosage:
50 nmol/kg
Administration:
I.p.
Result:
Improved Parkinson's disease symptom potentially and enhanced neurotransmission.
分子量
4875.49
CAS号
2315504-40-4
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Protect from light, stored under nitrogen
Powder
-80°C
2 years
-20°C
1 year
*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen)